Baillie Gifford & Co. Sells 143,607 Shares of Edwards Lifesciences Co. (NYSE:EW)
Baillie Gifford & Co. trimmed its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 40.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 208,696 shares of the medical research company’s stock after selling 143,607 […]
More Stories
Neurogene (NASDAQ:NGNE) Price Target Raised to $60.00
Neurogene (NASDAQ:NGNE – Free Report) had its price objective upped by Stifel Nicolaus from $44.00 to $60.00 in a research...
Tokio Marine Asset Management Co. Ltd. Has $2.52 Million Stock Position in Intercontinental Exchange, Inc. (NYSE:ICE)
Tokio Marine Asset Management Co. Ltd. raised its holdings in shares of Intercontinental Exchange, Inc. (NYSE:ICE – Free Report) by...
Valley Wealth Managers Inc. Purchases 8,833 Shares of Tapestry, Inc. (NYSE:TPR)
Valley Wealth Managers Inc. lifted its position in Tapestry, Inc. (NYSE:TPR – Free Report) by 2.1% during the 3rd quarter,...
Archer Investment Corp Lowers Stock Holdings in Tesla, Inc. (NASDAQ:TSLA)
Archer Investment Corp decreased its position in shares of Tesla, Inc. (NASDAQ:TSLA – Free Report) by 7.3% during the third...
WW International (NASDAQ:WW) Upgraded at StockNews.com
StockNews.com upgraded shares of WW International (NASDAQ:WW – Free Report) from a sell rating to a hold rating in a...
Applied Materials (NASDAQ:AMAT) Shares Gap Down Following Analyst Downgrade
Applied Materials, Inc. (NASDAQ:AMAT – Get Free Report)’s share price gapped down prior to trading on Friday after Bank of...